Lindbrook Capital, LLC Nuvasive Inc Transaction History

Lindbrook Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 24, 2023	BUY	$35.68 - $44.71 $3,068 - $3,845	86 Added 452.63%	105 $0
Q3 2022 Nov 10, 2022	SELL	$42.51 - $54.02 $12,880 - $16,368	-303 Reduced 94.1%	19 $1,000
Q2 2022 Aug 01, 2022	BUY	$46.84 - $59.75 $13,770 - $17,566	294 Added 1050.0%	322 $16,000
Q1 2022 Apr 21, 2022	BUY	$48.09 - $57.79 $1,346 - $1,618	28 New	28 $2,000
Q2 2020 Jul 27, 2020	SELL	$43.51 - $66.59 $913 - $1,398	-21 Closed	0 $0
Q1 2020 Apr 22, 2020	BUY	$32.82 - $81.13 $689 - $1,703	21 New	21 $1,000

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.